Ocular chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in an Italian referral center

L Berchicci, A Rabiolo, A Marchese, L Iuliano, C Gigliotti, Elisabetta Miserocchi, F Bandello, G Modorati

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose: This study aimed to assess the prevalence and clinical manifestations of ocular graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Methods: 269 patients who received allo-HSCT for hematologic malignancies were evaluated between December 2013 and April 2017 in this prospective observational study. Subjects underwent ophthalmologic examination at 6, 12 and 24 months after allo-HSCT. We evaluated the ophthalmologic and hematological data using the NIH consensus criteria definition and the International Chronic Ocular GVHD Consensus Group scoring systems. Results: According to NIH consensus criteria definition, ocular GVHD developed in 46.1%, 51.9% and 54.7% of patients at the follow-up visits. According to the International Chronic Ocular GVHD Consensus Group, ocular GVHD developed in 41.3%, 47.7% and 51.9% of patients at the follow-up visits. We found a strong association between the presence of systemic GVHD and the development of chronic ocular GVHD throughout the entire follow-up period. Weaker associations were found between the presence of a female donor, matched related donor, conjunctival hyperemia and conjunctival fibrosis. Conclusions: More than 50% of subjects develop chronic ocular GVHD after allo-HSCT. The presence of active systemic GVHD, female donor and matched related donor are associated with ocular GVHD development. © 2018
Original languageEnglish
Pages (from-to)314-321
Number of pages8
JournalOcular Surface
Volume16
Issue number3
DOIs
Publication statusPublished - 2018

Fingerprint Dive into the research topics of 'Ocular chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in an Italian referral center'. Together they form a unique fingerprint.

Cite this